122.4K XNAS Volume
XNAS 20 Mar, 2025 12:55 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 06 Mar 2025 | 5,000 | 2,290,731 (4%) | 0% | 5.0 | 25,100 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 06 Mar 2025 | 5,000 | 2,295,731 (4%) | 0% | 5.0 | 25,050 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 05 Mar 2025 | 5,000 | 2,285,731 (4%) | 0% | 5.0 | 25,150 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 05 Mar 2025 | 5,000 | 2,280,731 (4%) | 0% | 5.0 | 25,050 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 01 Mar 2025 | 10,000 | 2,275,731 (4%) | 0% | 4.7 | 47,050 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 95,999 | 2,265,731 (4%) | 0% | 4.8 | 456,955 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 26,941 | 411,628 (0%) | 0% | 4.8 | 128,239 | Common Stock |
| Timothy Williams | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 26,941 | 294,884 (0%) | 0% | 4.8 | 128,239 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 15,520 | 239,269 (0%) | 0% | 4.8 | 73,875 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 26,941 | 328,822 (0%) | 0% | 4.8 | 128,239 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 28 Feb 2025 | 10,000 | 2,361,730 (4%) | 0% | 4.8 | 47,600 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 27 Feb 2025 | 10,000 | 2,351,730 (4%) | 0% | 4.8 | 47,600 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 26 Feb 2025 | 5,000 | 2,341,730 (4%) | 0% | 4.8 | 23,900 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 26 Feb 2025 | 5,000 | 2,336,730 (4%) | 0% | 4.8 | 23,750 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.46 per share. | 25 Feb 2025 | 10,000 | 2,331,730 (4%) | 0% | 4.5 | 44,640 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 21 Feb 2025 | 2,000 | 355,763 (0%) | 0% | 4.4 | 8,779 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 450,000 | 2,321,730 (4%) | 0% | 0 | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 438,569 (0%) | 0% | 0 | Common Stock | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 321,825 (0%) | 0% | 0 | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 254,789 (0%) | 0% | 0 | Common Stock | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 353,763 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 14 Nov 2024 | 5,000 | 44,857 (0%) | 0% | 5.2 | 25,863 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 5.92 per share. | 29 Jul 2024 | 2,251 | 228,763 (0%) | 0% | 5.9 | 13,327 | Common Stock |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 40,202 | 40,202 | - | - | Stock Option (right to buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 21,887 | 64,125 (0%) | 0% | 0 | Common Stock | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 118,229 (0%) | 0% | 0 | Common Stock | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (Right to Buy) | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 59,842 (0%) | 0% | 0 | Common Stock | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 49,857 (0%) | 0% | 0 | Common Stock | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (right to buy) | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 64,244 (0%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 04 Mar 2024 | 24,288 | 1,871,730 (3%) | 0% | 4.1 | 100,273 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 04 Mar 2024 | 30,884 | 1,896,018 (3%) | 0% | 4.2 | 131,066 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 04 Mar 2024 | 8,727 | 322,253 (0%) | 0% | 4.3 | 37,495 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 04 Mar 2024 | 8,684 | 313,569 (0%) | 0% | 4.1 | 35,884 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 04 Mar 2024 | 8,147 | 205,766 (0%) | 0% | 4.4 | 35,917 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 04 Mar 2024 | 8,941 | 196,825 (0%) | 0% | 4.2 | 37,396 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 4.21 per share. | 04 Mar 2024 | 9,229 | 129,789 (0%) | 0% | 4.2 | 38,830 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 04 Mar 2024 | 7,498 | 139,018 (0%) | 0% | 4.4 | 33,091 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 04 Mar 2024 | 5,798 | 239,916 (0%) | 0% | 4.5 | 25,982 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 04 Mar 2024 | 8,902 | 231,014 (0%) | 0% | 4.2 | 37,411 | Common Stock |
| Williams Timothy | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 125,000 | 213,913 (0%) | 0% | 0 | Common Stock | |
| Wijkstrom Joakim | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 32,700 | 146,516 (0%) | 0% | 0 | Common Stock | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 125,000 | 245,714 (0%) | 0% | 0 | Common Stock | |
| Birznieks Gunther | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 125,000 | 330,980 (0%) | 0% | 0 | Common Stock | |
| Hristos Polymeropoulos Mihael | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 450,000 | 1,926,902 (3%) | 0% | 0 | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 21 Aug 2023 | 3,724 | 113,816 (0%) | 0% | 5.8 | 21,748 | Common Stock |
| Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 10 Aug 2023 | 6,500 | 29,328 (0%) | 0% | 6.1 | 39,349 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 28 Jul 2023 | 412 | 122,514 (0%) | 0% | 6.3 | 2,596 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 28 Jul 2023 | 1,800 | 120,714 (0%) | 0% | 6.3 | 11,349 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 15 Jun 2023 | 16,000 | 122,926 (0%) | 0% | 6.3 | 100,710 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.56 per share. | 13 Jun 2023 | 14,600 | 88,913 (0%) | 0% | 6.6 | 95,754 | Common Stock |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 97,700 (0%) | 0% | 0 | Common Stock | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 42,238 (0%) | 0% | 0 | Common Stock | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (right to buy) | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 39,313 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 35,828 (0%) | 0% | 0 | Common Stock | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 43,715 (0%) | 0% | 0 | Common Stock | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (right to buy) | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 51,276 | 51,276 | - | - | Stock Option (right to buy) | |
| Tage Honore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 26,408 | 26,408 (0%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 02 Mar 2023 | 22,426 | 1,499,440 (2%) | 0% | 6.2 | 139,718 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 02 Mar 2023 | 22,538 | 1,476,902 (2%) | 0% | 6.3 | 140,876 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 6.20 per share. | 02 Mar 2023 | 8,509 | 214,248 (0%) | 0% | 6.2 | 52,793 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 02 Mar 2023 | 8,268 | 205,980 (0%) | 0% | 6.3 | 51,791 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 02 Mar 2023 | 8,301 | 103,513 (0%) | 0% | 6.3 | 51,887 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.24 per share. | 02 Mar 2023 | 8,437 | 111,814 (0%) | 0% | 6.2 | 52,685 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 02 Mar 2023 | 4,113 | 117,540 (0%) | 0% | 6.3 | 25,994 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 02 Mar 2023 | 7,720 | 121,653 (0%) | 0% | 6.2 | 48,123 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 6.28 per share. | 02 Mar 2023 | 5,968 | 138,926 (0%) | 0% | 6.3 | 37,499 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 02 Mar 2023 | 7,966 | 144,894 (0%) | 0% | 6.3 | 49,846 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 115,000 | 1,521,866 (2%) | 0% | 0 | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 222,757 (0%) | 0% | 0 | Common Stock | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 120,251 (0%) | 0% | 0 | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 129,373 (0%) | 0% | 0 | Common Stock | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 152,860 (0%) | 0% | 0 | Common Stock | |
| Kevin Moran | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 06 Dec 2022 | 7,500 | 124,952 (0%) | 0% | 3.1 | 23,400 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 06 Dec 2022 | 4,792 | 120,160 (0%) | 0% | 10.6 | 50,827 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 05 Dec 2022 | 75,365 | 1,455,116 (2%) | 0% | 3.1 | 235,139 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 10.62 per share. | 05 Dec 2022 | 47,650 | 1,379,751 (2%) | 0% | 10.6 | 506,200 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 05 Dec 2022 | 74,635 | 1,427,401 (2%) | 0% | 3.1 | 232,861 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 75,365 | 0 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 74,635 | 75,365 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 05 Dec 2022 | 48,250 | 1,406,866 (2%) | 0% | 10.6 | 512,082 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 26 Aug 2022 | 1,250 | 190,057 (0%) | 0% | 3.1 | 3,900 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 1,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 22 Aug 2022 | 3,605 | 96,673 (0%) | 0% | 10.3 | 37,007 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.21 per share. | 15 Aug 2022 | 4,611 | 95,551 (0%) | 0% | 10.2 | 47,065 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.42 per share. | 15 Aug 2022 | 3,689 | 100,162 (0%) | 0% | 10.4 | 38,439 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 10.97 per share. | 28 Jul 2022 | 2,239 | 117,452 (0%) | 0% | 11.0 | 24,562 | Common Stock |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 80,393 (0%) | 0% | 0 | Common Stock | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 24,931 (0%) | 0% | 0 | Common Stock | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 22,006 (0%) | 0% | 0 | Common Stock | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 18,521 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 13 Jun 2022 | 2,700 | 6,515 (0%) | 0% | 9.5 | 25,593 | Common Stock |
| Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas H. Watkins | Director | Sale of securities on an exchange or to another person at price $ 9.90 per share. | 02 Jun 2022 | 6,441 | 63,064 (0%) | 0% | 9.9 | 63,779 | Common Stock |
| Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 02 Jun 2022 | 15,000 | 69,505 (0%) | 0% | 4.2 | 62,250 | Common Stock |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 31 May 2022 | 15,000 | 74,887 (0%) | 0% | 4.2 | 62,250 | Common Stock |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | Director | Sale of securities on an exchange or to another person at price $ 9.85 per share. | 31 May 2022 | 6,500 | 68,387 (0%) | 0% | 9.9 | 64,052 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 115,000 | 1,389,862 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 11.15 per share. | 28 Feb 2022 | 29,588 | 1,352,766 (2%) | 0% | 11.2 | 329,945 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 7,508 | 1,382,354 (2%) | 0% | 11.2 | 84,015 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 11.27 per share. | 28 Feb 2022 | 11,517 | 188,807 (0%) | 0% | 11.3 | 129,792 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 204,408 (0%) | 0% | 0 | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 4,084 | 200,324 (0%) | 0% | 11.2 | 45,700 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 28 Feb 2022 | 12,060 | 103,851 (0%) | 0% | 11.1 | 133,779 | Common Stock |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 115,911 (0%) | 0% | 0 | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 107,252 (0%) | 0% | 0 | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 6,974 | 100,278 (0%) | 0% | 11.2 | 78,060 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 11.28 per share. | 28 Feb 2022 | 8,832 | 119,691 (0%) | 0% | 11.3 | 99,650 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 131,996 (0%) | 0% | 0 | Common Stock | |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 3,473 | 128,523 (0%) | 0% | 11.2 | 38,863 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.88 per share. | 30 Nov 2021 | 78,324 | 1,299,386 (2%) | 0% | 4.9 | 382,221 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 71,676 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 78,324 | 71,676 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 30 Nov 2021 | 46,200 | 1,274,862 (2%) | 0% | 16.0 | 739,348 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.88 per share. | 30 Nov 2021 | 71,676 | 1,321,062 (2%) | 0% | 4.9 | 349,779 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 30 Nov 2021 | 50,000 | 1,249,386 (2%) | 0% | 16.5 | 824,275 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 15 Sep 2021 | 7,842 | 98,804 (0%) | 0% | 11.3 | 88,771 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 7,842 | 47,158 | - | - | Employee Stock Option (Right to Buy) | |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 4,277 | 33,224 | - | - | Employee Stock Option (Right to Buy) | |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 15 Sep 2021 | 16,824 | 81,980 (0%) | 0% | 16.5 | 277,394 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 15 Sep 2021 | 4,277 | 90,962 (0%) | 0% | 12.3 | 52,479 | Common Stock |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 09 Sep 2021 | 13,124 | 28,324 (0%) | 0% | 12.7 | 166,675 | Common Stock |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 13,124 | 21,876 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 5,985 | 0 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 09 Sep 2021 | 19,109 | 9,215 (0%) | 0% | 16.7 | 319,976 | Common Stock |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.57 per share. | 09 Sep 2021 | 5,985 | 15,200 (0%) | 0% | 10.6 | 63,261 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 20 Aug 2021 | 3,650 | 74,552 (0%) | 0% | 15.4 | 56,190 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 16.15 per share. | 16 Aug 2021 | 3,715 | 83,211 (0%) | 0% | 16.1 | 59,989 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 19.24 per share. | 28 Jul 2021 | 2,130 | 99,296 (0%) | 0% | 19.2 | 40,973 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 26 Jul 2021 | 7,250 | 86,685 (0%) | 0% | 19.7 | 142,776 | Common Stock |
| Stephen Ray Mitchell | Director | Sale of securities on an exchange or to another person at price $ 19.42 per share. | 15 Jun 2021 | 5,000 | 9,215 (0%) | 0% | 19.4 | 97,122 | Common Stock |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 4,015 | 5,985 | - | - | Stock Option (right to buy) | |
| Stephen Ray Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.57 per share. | 15 Jun 2021 | 4,015 | 14,215 (0%) | 0% | 10.6 | 42,439 | Common Stock |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 59,887 (0%) | 0% | 0 | Common Stock | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| H. Thomas Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| H. Thomas Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 54,505 (0%) | 0% | 0 | Common Stock | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 10,200 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 15 Mar 2021 | 15,000 | 111,935 (0%) | 0% | 11.3 | 169,800 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 17.72 per share. | 15 Mar 2021 | 18,000 | 93,935 (0%) | 0% | 17.7 | 319,010 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 15,000 | 55,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 08 Mar 2021 | 175,000 | 1,221,062 (2%) | 0% | 18.0 | 3,150,053 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 05 Mar 2021 | 5,400 | 86,926 (0%) | 0% | 17.9 | 96,390 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 17.88 per share. | 05 Mar 2021 | 200 | 92,326 (0%) | 0% | 17.9 | 3,576 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 02 Mar 2021 | 3,865 | 96,935 (0%) | 0% | 18.0 | 69,717 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 18.45 per share. | 02 Mar 2021 | 3,888 | 78,202 (0%) | 0% | 18.4 | 71,729 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 01 Mar 2021 | 15,206 | 1,396,062 (2%) | 0% | 18.3 | 278,902 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.45 per share. | 01 Mar 2021 | 7,479 | 1,411,268 (2%) | 0% | 18.5 | 138,003 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 18.19 per share. | 01 Mar 2021 | 16,620 | 171,708 (0%) | 0% | 18.2 | 302,273 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 18.66 per share. | 01 Mar 2021 | 3,845 | 188,328 (0%) | 0% | 18.7 | 71,744 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 01 Mar 2021 | 7,674 | 92,526 (0%) | 0% | 18.5 | 142,307 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 01 Mar 2021 | 11,856 | 100,200 (0%) | 0% | 18.6 | 220,543 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 18.23 per share. | 01 Mar 2021 | 6,044 | 101,426 (0%) | 0% | 18.2 | 110,191 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 18.57 per share. | 01 Mar 2021 | 3,327 | 107,470 (0%) | 0% | 18.6 | 61,780 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 115,000 | 1,418,747 (2%) | 0% | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 275,000 | 275,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 32,700 | 192,173 (0%) | 0% | - | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 77,500 | 77,500 | - | - | Employee Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 32,700 | 112,056 (0%) | 0% | - | Common Stock | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 77,500 | 77,500 | - | - | Employee Stock Option (Right to Buy) | |
| Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 61,200 | 61,200 | - | - | Employee Stock Option (Right to Buy) | |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 24 Feb 2021 | 22,499 | 123,786 (0%) | 0% | 12.3 | 276,063 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,800 | 101,287 (0%) | 0% | - | Common Stock | |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 24 Feb 2021 | 22,986 | 100,800 (0%) | 0% | 20.0 | 460,033 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 22,499 | 37,501 | - | - | Employee Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,800 | 82,090 (0%) | 0% | - | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 61,200 | 61,200 | - | - | Employee Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 77,500 | 77,500 | - | - | Employee Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 32,700 | 110,797 (0%) | 0% | - | Common Stock | |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.11 per share. | 16 Feb 2021 | 15,000 | 60,641 (0%) | 0% | 7.1 | 106,650 | Common Stock |
| Richard W. Dugan | Director | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 16 Feb 2021 | 5,754 | 54,887 (0%) | 0% | 18.5 | 106,663 | Common Stock |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Thomas Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.11 per share. | 16 Feb 2021 | 15,000 | 55,323 (0%) | 0% | 7.1 | 106,650 | Common Stock |
| H. Thomas Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| H. Thomas Watkins | Director | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 16 Feb 2021 | 5,818 | 49,505 (0%) | 0% | 18.5 | 107,856 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.88 per share. | 11 Dec 2020 | 35,053 | 1,285,763 (2%) | 0% | 12.9 | 451,360 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 41,817 | 1,320,816 (2%) | 0% | 8.8 | 365,899 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 46,663 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 61,520 | 46,663 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 41,817 | 108,183 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 11 Dec 2020 | 39,150 | 1,303,747 (2%) | 0% | 13.0 | 508,844 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 46,663 | 1,342,897 (2%) | 0% | 8.7 | 408,301 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 11 Dec 2020 | 51,049 | 1,296,234 (2%) | 0% | 13.2 | 673,306 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 61,520 | 1,347,283 (2%) | 0% | 8.8 | 538,300 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 11.08 per share. | 20 Aug 2020 | 3,710 | 56,290 (0%) | 0% | 11.1 | 41,109 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 11.81 per share. | 14 Aug 2020 | 3,684 | 79,356 (0%) | 0% | 11.8 | 43,526 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 11.81 per share. | 12 Aug 2020 | 7,200 | 75,487 (0%) | 0% | 11.8 | 85,018 | Common Stock |
| Aranthan Jones | Chief Corp. Affairs Officer | Sale of securities on an exchange or to another person at price $ 10.62 per share. | 27 Jul 2020 | 7,313 | 82,687 (0%) | 0% | 10.6 | 77,631 | Common Stock |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Kevin Moran | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 17,344 | 78,097 (0%) | 0% | - | Common Stock | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 45,641 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 40,323 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Anne Sempowski Ward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 5,200 (0%) | 0% | 0 | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2020 | 15,000 | 0 | - | - | Nonstatutory Stock Option (Right to Buy) | |
| Thomas H. Watkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.38 per share. | 29 May 2020 | 15,000 | 45,000 (0%) | 0% | 7.4 | 110,700 | Common Stock |
| Thomas H. Watkins | Director | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 29 May 2020 | 9,677 | 35,323 (0%) | 0% | 11.5 | 111,286 | Common Stock |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.38 per share. | 28 May 2020 | 15,000 | 50,770 (0%) | 0% | 7.4 | 110,700 | Common Stock |
| Richard W. Dugan | Director | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 28 May 2020 | 10,129 | 40,641 (0%) | 0% | 11.0 | 111,806 | Common Stock |
| Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 15,000 | 0 | - | - | Nonstatutory Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.57 per share. | 02 Mar 2020 | 10,428 | 1,284,151 (2%) | 0% | 10.6 | 110,211 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.98 per share. | 02 Mar 2020 | 5,152 | 1,278,999 (2%) | 0% | 11.0 | 56,544 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.19 per share. | 02 Mar 2020 | 12,968 | 192,758 (0%) | 0% | 10.2 | 132,087 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.76 per share. | 02 Mar 2020 | 5,889 | 186,869 (0%) | 0% | 10.8 | 63,359 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 02 Mar 2020 | 1,450 | 165,384 (0%) | 0% | 10.2 | 14,755 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 02 Mar 2020 | 12,223 | 165,008 (0%) | 0% | 10.0 | 122,686 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 10.66 per share. | 02 Mar 2020 | 5,535 | 159,473 (0%) | 0% | 10.7 | 58,984 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 02 Mar 2020 | 1,237 | 83,040 (0%) | 0% | 10.5 | 13,004 | Common Stock |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 02 Mar 2020 | 3,148 | 84,277 (0%) | 0% | 10.3 | 32,436 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 140,000 | 140,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 60,000 | 1,294,579 (2%) | 0% | - | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 30,000 | 177,231 (0%) | 0% | - | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 30,000 | 87,425 (0%) | 0% | - | Common Stock | |
| Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 30,000 | 90,000 (0%) | 0% | - | Common Stock | |
| Aranthan Jones | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2020 | 30,000 | 60,000 (0%) | 0% | - | Common Stock | |
| Stephen Ray Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2020 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 02 Jan 2020 | 9,467 | 1,234,579 (2%) | 0% | 16.0 | 151,493 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.94 per share. | 02 Jan 2020 | 4,020 | 205,726 (0%) | 0% | 15.9 | 64,086 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.06 per share. | 02 Jan 2020 | 1,155 | 166,834 (0%) | 0% | 16.1 | 18,551 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 15.93 per share. | 02 Jan 2020 | 4,020 | 147,231 (0%) | 0% | 15.9 | 64,021 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 11 Dec 2019 | 70,036 | 1,244,046 (2%) | 0% | 17.0 | 1,189,351 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 85,801 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 89,199 | 85,801 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.65 per share. | 11 Dec 2019 | 89,199 | 1,300,654 (2%) | 0% | 10.6 | 949,969 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.65 per share. | 11 Dec 2019 | 85,801 | 1,314,082 (2%) | 0% | 10.7 | 913,781 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.92 per share. | 11 Dec 2019 | 72,373 | 1,228,281 (2%) | 0% | 16.9 | 1,224,377 | Common Stock |
| Anne Sempowski Ward | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2019 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Richard W. Dugan | None | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 26 Aug 2019 | 15,000 | 35,770 (0%) | 0% | 14.9 | 222,750 | Common Stock |
| Richard W. Dugan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2019 | 15,000 | 0 | - | - | Nonstatutory Stock Option (Right to Buy) | |
| Richard W. Dugan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.78 per share. | 26 Aug 2019 | 15,000 | 50,770 (0%) | 0% | 14.8 | 221,700 | Common Stock |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2019 | 30,000 | 30,000 (0%) | 0% | - | Common Stock | |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2019 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Sale of securities on an exchange or to another person at price $ 14.69 per share. | 14 Aug 2019 | 2,575 | 57,425 (0%) | 0% | 14.7 | 37,829 | Common Stock |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 5,000 | 35,770 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 5,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 5,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Phaedra Chrousos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Phaedra Chrousos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2019 | 73,608 | 79,019 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.55 per share. | 17 May 2019 | 97,373 | 1,276,343 (2%) | 0% | 12.5 | 1,222,031 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.56 per share. | 17 May 2019 | 77,225 | 1,199,118 (2%) | 0% | 15.6 | 1,201,691 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.55 per share. | 17 May 2019 | 73,608 | 1,272,726 (2%) | 0% | 12.5 | 923,780 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 17 May 2019 | 67,418 | 1,205,308 (2%) | 0% | 15.1 | 1,019,084 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.55 per share. | 17 May 2019 | 79,019 | 1,284,327 (2%) | 0% | 12.5 | 991,688 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.34 per share. | 17 May 2019 | 72,872 | 1,211,455 (2%) | 0% | 15.3 | 1,117,951 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2019 | 97,373 | 152,627 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2019 | 79,019 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Phaedra Chrousos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2019 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 01 Mar 2019 | 6,500 | 1,217,136 (2%) | 0% | 20.2 | 131,424 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.41 per share. | 01 Mar 2019 | 38,166 | 1,178,970 (2%) | 0% | 19.4 | 740,802 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 01 Mar 2019 | 4,976 | 218,497 (0%) | 0% | 20.2 | 100,271 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.88 per share. | 01 Mar 2019 | 8,751 | 209,746 (0%) | 0% | 19.9 | 173,961 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 01 Mar 2019 | 438 | 168,432 (0%) | 0% | 20.2 | 8,832 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 01 Mar 2019 | 443 | 167,989 (0%) | 0% | 19.9 | 8,823 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 19.89 per share. | 01 Mar 2019 | 8,788 | 151,251 (0%) | 0% | 19.9 | 174,767 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 20.13 per share. | 01 Mar 2019 | 3,741 | 160,039 (0%) | 0% | 20.1 | 75,325 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 140,000 | 140,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 60,000 | 1,223,636 (2%) | 0% | - | Common Stock | |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 30,000 | 223,473 (0%) | 0% | - | Common Stock | |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 30,000 | 168,870 (0%) | 0% | - | Common Stock | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 30,000 | 163,780 (0%) | 0% | - | Common Stock | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 30,000 | 60,000 (0%) | 0% | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jan 2019 | 4,000 | 1,178,872 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 02 Jan 2019 | 4,447 | 1,163,636 (2%) | 0% | 26.0 | 115,804 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.93 per share. | 02 Jan 2019 | 3,056 | 1,168,083 (2%) | 0% | 26.9 | 82,310 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.32 per share. | 02 Jan 2019 | 7,733 | 1,171,139 (2%) | 0% | 26.3 | 203,548 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.94 per share. | 02 Jan 2019 | 1,129 | 195,092 (0%) | 0% | 26.9 | 30,414 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.31 per share. | 02 Jan 2019 | 3,313 | 196,221 (0%) | 0% | 26.3 | 87,165 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.09 per share. | 02 Jan 2019 | 1,619 | 193,473 (0%) | 0% | 26.1 | 42,232 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 26.94 per share. | 02 Jan 2019 | 530 | 138,870 (0%) | 0% | 26.9 | 14,276 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 02 Jan 2019 | 600 | 139,400 (0%) | 0% | 26.3 | 15,767 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 26.09 per share. | 02 Jan 2019 | 1,619 | 133,780 (0%) | 0% | 26.1 | 42,232 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 26.95 per share. | 02 Jan 2019 | 1,170 | 135,399 (0%) | 0% | 26.9 | 31,528 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 02 Jan 2019 | 3,272 | 136,569 (0%) | 0% | 26.3 | 86,050 | Common Stock |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2018 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| Timothy Williams | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2018 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 5,000 | 30,770 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 5,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Milano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2018 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Thomas H. Watkins | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2018 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas H. Watkins | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 03 May 2018 | 15,000 | 20,000 (0%) | 0% | 5.0 | 74,700 | Common Stock |
| Richard W. Dugan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 19 Mar 2018 | 15,000 | 25,770 (0%) | 0% | 5.0 | 74,700 | Common Stock |
| Richard W. Dugan | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2018 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 140,000 | 140,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 60,000 | 1,243,838 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 28 Feb 2018 | 60,966 | 1,182,872 (2%) | 0% | 18.7 | 1,141,003 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 28 Feb 2018 | 8,532 | 199,534 (0%) | 0% | 18.7 | 159,712 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 40,000 | 208,066 (0%) | 0% | 0 | Common Stock | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 30,000 | 140,000 (0%) | 0% | 0 | Common Stock | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 30,000 | 118,733 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 28 Feb 2018 | 3,660 | 115,073 (0%) | 0% | 18.7 | 68,473 | Common Stock |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 30,000 | 148,366 (0%) | 0% | 0 | Common Stock | |
| Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2018 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 28 Feb 2018 | 8,525 | 139,841 (0%) | 0% | 18.7 | 159,605 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 02 Jan 2018 | 170,225 | 1,111,623 (2%) | 0% | 15.3 | 2,603,728 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 250,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 0 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 12,500 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 18,750 | 37,500 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jan 2018 | 10,000 | 1,031,848 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.76 per share. | 02 Jan 2018 | 250,000 | 1,281,848 (2%) | 0% | 5.8 | 1,440,000 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 1,124,123 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 1,149,123 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 18,750 | 1,205,373 (2%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 02 Jan 2018 | 21,535 | 1,183,838 (2%) | 0% | 15.3 | 329,399 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 15,000 | - | - | Restricted Stock Unit | |
| James Kelly | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.35 per share. | 02 Jan 2018 | 9,155 | 168,066 (0%) | 0% | 15.3 | 140,494 | Common Stock |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 177,221 (0%) | 0% | 0 | Common Stock | |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 5,000 | 154,721 (0%) | 0% | 0 | Common Stock | |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 5,000 | 144,721 (0%) | 0% | 0 | Common Stock | |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 5,000 | 0 | - | - | Restricted Stock Unit | |
| James Kelly | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 15,000 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 25,000 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 87,500 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 76,600 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Sale of securities on an exchange or to another person at price $ 15.20 per share. | 02 Jan 2018 | 10,367 | 88,733 (0%) | 0% | 15.2 | 157,565 | Common Stock |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 99,100 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 12,500 | 25,000 | - | - | Restricted Stock Unit | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2018 | 7,500 | 15,000 | - | - | Restricted Stock Unit | |
| Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 02 Jan 2018 | 8,568 | 118,366 (0%) | 0% | 15.3 | 130,777 | Common Stock |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 5,000 | 10,770 (0%) | 0% | 0 | Common Stock | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Thomas H. Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Milano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Kenneth M. Bate | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth M. Bate | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2017 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 275,000 | 275,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 200,000 | 1,041,848 (0%) | 0% | 0 | Restricted Stock Unit | |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Kelly | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 70,000 | 139,721 (0%) | 0% | 0 | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 30,000 | 50,000 (0%) | 0% | 0 | Restricted Stock Unit | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 30,000 | 39,100 (0%) | 0% | 0 | Restricted Stock Unit | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2017 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.48 per share. | 03 Jan 2017 | 23,330 | 850,848 (1%) | 0% | 15.5 | 361,242 | Common Stock |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 6,250 | 830,428 (1%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 842,928 (1%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 18,750 | 874,178 (1%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 855,428 (1%) | 0% | 0 | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 6,250 | 0 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 12,500 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 25,000 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 18,750 | 56,250 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 53,165 (0%) | 0% | 0 | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 10,000 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 0 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 58,165 (0%) | 0% | 0 | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 63,165 (0%) | 0% | 0 | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 70,665 (0%) | 0% | 0 | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 03 Jan 2017 | 16,300 | 54,365 (0%) | 0% | 15.5 | 252,776 | Common Stock |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 2,344 | 0 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 68,116 (0%) | 0% | 0 | Common Stock | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 10,000 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 2,344 | 63,116 (0%) | 0% | 0 | Common Stock | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 5,000 | 73,116 (0%) | 0% | 0 | Common Stock | |
| James Kelly | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 80,616 (0%) | 0% | 0 | Common Stock | |
| James Kelly | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 03 Jan 2017 | 10,895 | 69,721 (0%) | 0% | 15.5 | 169,013 | Common Stock |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 37,500 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 37,500 | - | - | Restricted Stock Unit | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 03 Jan 2017 | 10,900 | 9,100 (0%) | 0% | 15.5 | 169,090 | Common Stock |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Richard L. Gulino | SVP, General Counsel & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2016 | 9,000 | 830,178 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 119,690 | 1,873,108 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 152,334 | 2,383,955 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 68,940 | 850,778 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 273,632 | 1,599,476 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 348,258 | 2,035,697 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Sep 2016 | 157,607 | 693,171 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 62,791 | 2,090,161 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 79,915 | 2,660,207 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 58,997 | 1,044,620 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 93,506 | 1,996,655 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 119,008 | 2,541,199 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 87,858 | 956,762 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 3,857 | 1,992,798 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 4,910 | 2,536,289 | - | - | Common Stock | |
| Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2016 | 37,044 | 919,718 | - | - | Common Stock | |
| Richard W. Dugan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2016 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kenneth M. Bate | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2016 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Michael F. Cola | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2016 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2016 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| H. Thomas Watkins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2016 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 75,000 | 75,000 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Paolo Baroldi | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO, Sec & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Kelly | SVP, CFO, Sec & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Gian Piero Reverberi | SVP, Acting CCO & GM Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gian Piero Reverberi | SVP, Acting CCO & GM Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Richard L. Gulino | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Richard L. Gulino | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2016 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 0 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 25,000 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 37,500 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 829,281 | - | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 6,250 | 835,531 | - | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 848,031 | - | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 860,531 | - | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jan 2016 | 21,353 | 839,178 | - | - | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 12,500 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 10,000 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 15,000 | - | - | Restricted Stock Unit | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 12,500 | 43,045 | - | - | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 48,045 | - | - | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 53,045 | - | - | Common Stock | |
| Paolo Baroldi | SVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jan 2016 | 12,380 | 40,665 | - | - | Common Stock | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 4,688 | 0 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 2,344 | 2,344 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 10,000 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 15,000 | - | - | Restricted Stock Unit | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 4,688 | 57,992 | - | - | Common Stock | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 2,344 | 60,336 | - | - | Common Stock | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 65,336 | - | - | Common Stock | |
| James Kelly | SVP, CFO, Sec & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2016 | 5,000 | 70,336 | - | - | Common Stock | |
| James Kelly | SVP, CFO, Sec & Treasurer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jan 2016 | 9,564 | 60,772 | - | - | Common Stock | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2015 | 15,000 | 801,781 | - | - | Common Stock | |
| Kenneth M. Bate | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2015 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2015 | 3,490 | 2,152,952 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2015 | 4,441 | 2,740,122 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2015 | 3,239 | 1,103,617 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 32,211 | 2,048,598 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 40,997 | 2,607,307 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 29,902 | 1,006,744 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 100,864 | 2,149,462 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 128,374 | 2,735,681 | - | - | Common Stock | |
| Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2015 | 93,634 | 1,100,378 | - | - | Common Stock | |
| Richard L. Gulino | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2015 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Richard L. Gulino | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2015 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2015 | 42,747 | 147,626 | - | - | Employee Stock Option (Right to Buy) |